Northwest & Ethical Investments’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-68,643
| Closed | -$2M | – | 496 |
|
|
2024
Q3 | $2M | Sell |
68,643
-7,192
| -9% | -$210K | 0.05% | 251 |
|
|
2024
Q2 | $1.76M | Hold |
75,835
| – | – | 0.05% | 257 |
|
|
2024
Q1 | $1.56M | Buy |
75,835
+4,551
| +6% | +$93.4K | 0.04% | 265 |
|
|
2023
Q4 | $1.53M | Sell |
71,284
-3,484
| -5% | -$74.8K | 0.05% | 251 |
|
|
2023
Q3 | $1.54M | Hold |
74,768
| – | – | 0.05% | 249 |
|
|
2023
Q2 | $2.21M | Sell |
74,768
-17,729
| -19% | -$523K | 0.07% | 240 |
|
|
2023
Q1 | $2.13M | Sell |
92,497
-2,366
| -2% | -$54.5K | 0.07% | 252 |
|
|
2022
Q4 | $2.64M | Buy |
94,863
+14,983
| +19% | +$417K | 0.09% | 217 |
|
|
2022
Q3 | $2.45M | Hold |
79,880
| – | – | 0.1% | 216 |
|
|
2022
Q2 | $2.35M | Hold |
79,880
| – | – | 0.09% | 221 |
|
|
2022
Q1 | $2.57M | Buy |
79,880
+48,280
| +153% | +$1.55M | 0.08% | 229 |
|
|
2021
Q4 | $1.41M | Buy |
+31,600
| New | +$1.41M | 0.04% | 267 |
|